Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that finasteride can reduce nandrolone detection in doping tests, suggesting frequent testing and setting metabolite level thresholds for detection.

Nanocarriers can improve skin treatments by effectively delivering drugs and enhancing skin hydration.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Urologists should screen for mental health issues before and during finasteride treatment.

The gel shows strong potential for effectively treating pressure ulcers.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The gel effectively delivers dutasteride for hair loss treatment and remains stable for 90 days.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

STAR particles can improve the effectiveness of topical hair growth treatments without causing skin irritation.

The study improved and was accepted despite initial concerns about data clarity, methodology, and potential overfitting.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Cepharanthine shows promise as a COVID-19 treatment.

Standardizing and engineering organoids can improve their use in medicine and drug testing.

The study created a tool that mimics natural cell signals, which increased cell growth and could help with hair regeneration research.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Chitosan nanoparticles are promising for sustained caffeine delivery through the skin.

Finasteride is effective in growing hair and stopping hair loss in men with mild to moderate alopecia.

FDA-approved low-level light/laser therapy devices can significantly increase hair density in people with pattern hair loss.

Leflunomide is more likely to help treat alopecia areata than cause it.

Combining plant extracts with nanotechnology may improve hair loss treatments.

A reliable UV method was created to measure finasteride accurately.